0001104659-22-075935.txt : 20220629 0001104659-22-075935.hdr.sgml : 20220629 20220629213633 ACCESSION NUMBER: 0001104659-22-075935 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20220627 FILED AS OF DATE: 20220629 DATE AS OF CHANGE: 20220629 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Sim Brandon CENTRAL INDEX KEY: 0001813532 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-37392 FILM NUMBER: 221056335 MAIL ADDRESS: STREET 1: C/O APOLLO MEDICAL HOLDINGS, INC. STREET 2: 1668 S. GARFIELD AVENUE, 3RD FLOOR CITY: ALHAMBRA STATE: CA ZIP: 91801 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Apollo Medical Holdings, Inc. CENTRAL INDEX KEY: 0001083446 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-MANAGEMENT CONSULTING SERVICES [8742] IRS NUMBER: 870042699 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 1668 S. GARFIELD AVENUE STREET 2: 2ND FLOOR CITY: ALHAMBRA STATE: CA ZIP: 91801 BUSINESS PHONE: (626) 282-0288 MAIL ADDRESS: STREET 1: 1668 S. GARFIELD AVENUE STREET 2: 2ND FLOOR CITY: ALHAMBRA STATE: CA ZIP: 91801 FORMER COMPANY: FORMER CONFORMED NAME: SICLONE INDUSTRIES INC DATE OF NAME CHANGE: 19990413 4 1 tm2220100-1_4seq1.xml OWNERSHIP DOCUMENT X0306 4 2022-06-27 0 0001083446 Apollo Medical Holdings, Inc. AMEH 0001813532 Sim Brandon 1668 S. GARFIELD AVE., 2ND FL. ALHAMBRA CA 91801 0 1 0 0 Co- Chief Executive Officer Common Stock 2022-06-27 4 A 0 108560 0 A 292623 D Common Stock 2022-06-27 4 A 0 198511 0 A 491134 D Restricted shares of the Issuer's common stock granted pursuant to the Issuer's 2015 Equity Incentive Plan. Provided the Reporting Person is still employed with the Issuer on the following dates, the shares of restricted stock shall vest in four equal annual installments commencing on the first anniversary of June 27, 2022. Restricted shares of the Issuer's common stock granted pursuant to the Issuer's 2015 Equity Incentive Plan. Provided the Reporting Person is still employed with the Issuer on the date of vesting, vesting of the restricted shares is based on achievement of pre-established financial performance goals on or before December 31, 2024. /s/ Brandon Sim 2022-06-29